Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy
Authors:
- Jaromira KovarovaJKJaromira Kovarova
- Martina BajzikovaMBMartina Bajzikova
- Magdalena VondrusovaMVMagdalena Vondrusova
- Jan StursaJSJan Stursa
- Jacob GoodwinJGJacob Goodwin
- Maria NguyenMNMaria Nguyen
- Renata ZobalovaRZRenata Zobalova
- Elham Alizadeh PesdarEPElham Alizadeh Pesdar
- Jaroslav TruksaJaroslav Truksa
- Marco TomasettiMarco Tomasetti
- Lan-Feng DongLDLan-Feng Dong
- Jiri NeuzilJNJiri Neuzil
- 12 November 2013
- journal article
- Published by Taylor & Francis in Redox Report
- Vol. 19 (1) , 16-25
Abstract
Malignant mesothelioma (MM) is a fatal neoplastic disease with no therapeutic option. Therefore, the search for novel therapies is of paramount importance. Since mitochondrial targeting of α-tocopheryl succinate (α-TOS) by its tagging with triphenylphosphonium enhances its cytotoxic effects to cancer cells, we tested its effect on MM cells and experimental mesotheliomas. Mitochondrially targeted vitamin E succinate (MitoVES) was more efficient in killing MM cells than α-TOS with IC₅₀ lower by up to two orders of magnitude. Mitochondrial association of MitoVES in MM cells was documented using its fluorescently tagged analogue. MitoVES caused apoptosis in MM cells by mitochondrial destabilization, resulting in the loss of mitochondrial membrane potential, generation of reactive oxygen species, and destabilization of respiratory supercomplexes. The role of the mitochondrial complex II in the activity of MitoVES was confirmed by the finding that MM cells with suppressed succinate quinone reductase were resistant to MitoVES. MitoVES suppressed mesothelioma growth in nude mice with high efficacy. MitoVES is more efficient in killing MM cells and suppressing experimental mesotheliomas compared with the non-targeted α-TOS, giving it a potential clinical benefit.Keywords
This publication has 39 references indexed in Scilit:
- Mitochondrial complex II, a novel target for anti-cancer agentsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-AnalysisJournal of Clinical Oncology, 2012
- (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivoLeukemia, 2011
- Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapyFree Radical Biology and Medicine, 2011
- Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex IIJournal of Biological Chemistry, 2011
- Involvement of Ca2+ and ROS in α‐tocopheryl succinate‐induced mitochondrial permeabilizationInternational Journal of Cancer, 2010
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex IIOncogene, 2008
- A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 ExpressionCancer Research, 2007
- α-Tocopheryl Succinate Inhibits Malignant Mesothelioma byDisrupting the Fibroblast Growth Factor Autocrine LoopJournal of Biological Chemistry, 2005
- α-Tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instabilityBiochemical Journal, 2002